DEBROSKI R HERBERT

Summary

Affiliation: Cincinnati Children's Hospital Medical Center
Country: USA

Publications

  1. pmc Trefoil factor 2 rapidly induces interleukin 33 to promote type 2 immunity during allergic asthma and hookworm infection
    Marsha Wills-Karp
    Division of Immunobiology and 2 Division of Asthma Research, Cincinnati Children s Hospital Medical Center, Cincinnati, OH 45229, USA
    J Exp Med 209:607-22. 2012
  2. pmc Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis
    De Broski R Herbert
    Research Service, Cincinnati Veterans Administration Medical Center, Cincinnati, OH 45220, USA
    J Immunol 184:6438-46. 2010

Research Grants

Detail Information

Publications2

  1. pmc Trefoil factor 2 rapidly induces interleukin 33 to promote type 2 immunity during allergic asthma and hookworm infection
    Marsha Wills-Karp
    Division of Immunobiology and 2 Division of Asthma Research, Cincinnati Children s Hospital Medical Center, Cincinnati, OH 45229, USA
    J Exp Med 209:607-22. 2012
    ..These experiments extend the biological functions of TFF2 from tissue repair to the initiation and maintenance of mucosal T(H)2 responses...
  2. pmc Arginase I suppresses IL-12/IL-23p40-driven intestinal inflammation during acute schistosomiasis
    De Broski R Herbert
    Research Service, Cincinnati Veterans Administration Medical Center, Cincinnati, OH 45220, USA
    J Immunol 184:6438-46. 2010
    ..Thus, macrophage-derived Arg I protects hosts against excessive tissue injury caused by worm eggs during acute schistosomiasis by suppressing IL-12/IL-23p40 production and maintaining the Treg/Th17 balance within the intestinal mucosa...

Research Grants2

  1. Alternative Macrophage Activation Limits Immunopathology
    DEBROSKI R HERBERT; Fiscal Year: 2010
    ..A greater mechanistic understanding of macrophage effector function on a molecular level of should allow for the design of novel therapeutic approaches to the myriad diseases whose expression is controlled by MF. ..
  2. Alternative Macrophage Activation Limits Immunopathology
    DEBROSKI R HERBERT; Fiscal Year: 2009
    ..A greater mechanistic understanding of macrophage effector function on a molecular level of should allow for the design of novel therapeutic approaches to the myriad diseases whose expression is controlled by MF. ..